KP-496
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Bronchial asthma is characterized by chronic airway inflammation. Eosinophils are involved in airway inflammation and play…
Aims: The aim of this study was to evaluate the effects of inhaled KP-496, a novel dual antagonist for cysteinyl leukotriene…
KP‐496 is a novel dual antagonist for cysteinyl leukotriene receptor 1 (CysLT1) and thromboxane A2 (TXA2) receptor (TP). The aim…
Abstract.Objective and design:KP-496 is a novel dual antagonist for leukotriene (LT) D4 and thromboxane (TX) A2 receptors. We…